Search Results1-8 of  8

  • Honma Yoshitaka ID: 9000361230012

    Articles in CiNii:1

    • Irinotecan monotherapy as third-line treatment for advanced gastric cancer refractory to fluoropyrimidines, platinum, and taxanes (2017)
  • Honma Yoshitaka ID: 9000368922165

    Articles in CiNii:1

    • Clinicopathological features and pathological evaluation of preoperative treatment of patients with resectable esophageal carcinosarcoma (2017)
  • Honma Yoshitaka ID: 9000390405196

    Articles in CiNii:1

    • A phase Ⅱ study of combination therapy with oral S-1 and cisplatin in elderly patients with advanced gastric cancer (2018)
  • Honma Yoshitaka ID: 9000403259667

    Articles in CiNii:1

    • Association between UGT1A1 gene polymorphism and safety and efficacy of irinotecan monotherapy as the third-line treatment for advanced gastric cancer (2019)
  • HONMA Yoshitaka ID: 9000004517159

    Graduate School of Science and Engineering, Yamagata University (2003 from CiNii)

    Articles in CiNii:2

    • A Direction Selective Zone Routing Protocol for Ad - Hoc Networks (2003)
    • A Direction Selective Zone Routing Protocol for Ad - Hoc Networks (2003)
  • HONMA Yoshitaka ID: 9000307257991

    Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital (2015 from CiNii)

    Articles in CiNii:1

    • Multidisciplinary therapy for esophagogastric junction cancer (2015)
  • Honma Yoshitaka ID: 9000021691763

    Articles in CiNii:1

    • Special Edition. Barcelona Olympic Games. 5. Open Studio. (1992)
  • Honma Yoshitaka ID: 9000345248444

    Gastrointestinal Medical Oncology Division, National Cancer Center Hospital (2015 from CiNii)

    Articles in CiNii:1

    • Risk Factors of Hand-foot Skin Reaction Caused by Regorafenib in Patients with Unresectable Advanced or Recurrent Colorectal Cancer (2015)
Page Top